Spring Sale Spring Sale

ADVERTISEMENT

Is Female Sexual Dysfunction Becoming a Product Line?

With female sexual dysfunction (FSD) affecting 43 percent of women ages 18-59 (approximately 50 million women in the United States alone), according to the Journal of the American Medical Association, some experts believe female sexual dysfunction is becoming a "product line."

The author of this new piece in the British Medical Journal has it right about the means a multi-national company has -- with huge budgets to burn -- to manipulate the process by which a new drug comes to market:

  • Raising public awareness about the condition the drug is designed to target.
  • Sponsoring key scientific meetings in sexual medicine.
  • Hiring leading sex researchers as consultants.
  • Funding continuing medical education activities.
  • Producing a reporter's guide to testosterone.
  • Creating a publicly accessible Web site.
  • Working with agents from public relations companies and advertising firms to promote awareness of both the disease and the drug.

However, the reporter did not understand the truth about the product he uses to illustrate this issue. Intrinsa, is really not a "drug" at all, but a natural bioidentical hormone. What the FDA and most doctors and patients do not realize is that bioidentical hormone supplements can actually optimize your body's own natural hormones so they reach a target level that corresponds to the reference ranges for healthy young adults.

When one provides a person with bioidentical hormones based on a proper hormone evaluation, either clinical exam, saliva, urine and/or blood levels, and monitor the therapy it can provide nearly miraculous improvement in the quality of life -- not only one's sex drive. In addition, this "drug" does not even need to be approved, as there are tens of thousands of physicians who have been using it for many years through a compounding pharmacist. In fact, I take it myself to optimize the aging process.

British Medical Journal January 22, 2005 2005;330:192-194 (free text article)

Click Here and be the first to comment on this article
Post your comment